The DOI matches its Crossref record; 505 of the 505 references it cites were found in a registry or an index.
Diabetic kidney disease
Open accessAbstract
The kidney is arguably the most important target of microvascular damage in diabetes. A substantial proportion of individuals with diabetes will develop kidney disease owing to their disease and/or other co-morbidity, including hypertension and ageing-related nephron loss. The presence and severity of chronic kidney disease (CKD) identify individuals who are at increased risk of adverse health outcomes and premature mortality. Consequently, preventing and managing CKD in patients with diabetes is now a key aim of their overall management. Intensive management of patients with diabetes includes controlling blood glucose levels and blood pressure as well as blockade of the renin–angiotensin–aldosterone system; these approaches will reduce the incidence of diabetic kidney disease and slow its progression. Indeed, the major decline in the incidence of diabetic kidney disease (DKD) over the past 30 years and improved patient prognosis are largely attributable to improved diabetes care. However, there remains an unmet need for innovative treatment strategies to prevent, arrest, treat and reverse DKD. In this Primer, we summarize what is now known about the molecular pathogenesis of CKD in patients with diabetes and the key pathways and targets implicated in its progression. In addition, we discuss the current evidence for the prevention and management of DKD as well as the many controversies. Finally, we explore the opportunities to develop new interventions through urgently needed investment in dedicated and focused research. For an illustrated summary of this Primer, visit: http://go.nature.com/NKHDzg
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–505 of 505
Improving Care of Patients With Diabetes and CKD: A Pilot Study for a Cluster-Randomized Trial
Cortés–Sanabria, L., Cabrera-Pivaral, C. E., Cueto-Manzano, A. M., Campos, E. R., Barragán, G., Hernández-Anaya, M., & Martínez–Ramírez, H. R. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.12.039 · Cited by 66
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
Schernthaner, G., Mogensen, C. E., & Schernthaner, G.-H. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114542802 · Cited by 66
Insulin signaling: implications for podocyte biology in diabetic kidney disease
Coward, R. J., & Fornoni, A. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000078 · Cited by 65
Zoppini, G., Galletti, A. M. R., Targher, G., Brangani, C., Pichiri, I., Trombetta, M., Negri, C., Santi, F. D., Stoico, V., Cacciatori, V., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000058 · Cited by 65
Goldstein, D. A., & Massry, S. G. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181239 · Cited by 64
Miller, E. R., Juraschek, S. P., Anderson, C. A. M., Güallar, E., Henoch-Ryugo, K., Charleston, J. B., Turban, S., BENNETT, M. R., & Appel, L. J. (2012) · Diabetes Care · doi:10.2337/dc12-1940 · Cited by 63
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial
Leehey, D. J., Zhang, J. H., Emanuele, N. V., Whaley-Connell, A., Palevsky, P. M., Reilly, R. F., Guarino, P., & Fried, L. F. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02850315 · Cited by 62
Early nephropathy in type 1 diabetes: the importance of early renal function decline
Perkins, B. A., & Królewski, A. S. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283293db1 · Cited by 62
Fotheringham, J., Campbell, M. J., Fogarty, D. G., Nahas, M. E., & Ellam, T. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.08.009 · Cited by 62
Towards understanding the inherited susceptibility for nephropathy in diabetes
Thomas, M. C., Groop, P., & Tryggvason, K. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328350313e · Cited by 62
Self-citationRenal and Cardiovascular Protection in Type 2 Diabetes Mellitus: Angiotensin II Receptor Blockers
Deferrari, G., Ravera, M., Deferrari, L., Vettoretti, S., Ratto, E., & Parodi, D. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032544.37147.ae · Cited by 60
Hotu, C., Bagg, W., Collins, J. F., Harwood, L., WHALLEY, G. A., Doughty, R. N., Gamble, G. D., Braatvedt, G. D., & on behalf of the DEFEND investigators (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq168 · Cited by 60
Thurman, J. M., & Schrier, R. W. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00090-1 · Cited by 59
Mäkinen, V., Soininen, P., Kangas, A. J., Forsblom, C. M., Tolonen, N., Thorn, L. M., Viikari, J. S. A., Raitakari, O. T., Savolainen, M. J., Groop, P., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12026 · Cited by 58
Self-citationLong-Term Renoprotective Effects of Losartan in Diabetic Nephropathy
Andersen, S., Tarnow, L., Cambien, F., Rossing, P. R., Juhl, T. R., Deinum, J., & Parving, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1501 · Cited by 58
Self-citationDiabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis.
Lewis, A., Steadman, R., Manley, P., Craig, K. J., de la Motte, C., Hascall, V., & Phillips, A. O. (2008) · PubMed · doi:10.14670/hh-23.731 · Cited by 57
Temporal Profile of Diabetic Nephropathy Pathologic Changes
Ponchiardi, C., Mauer, M. S., & Najafian, B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0395-7 · Cited by 57
Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes
Winkelmayer, W. C., Zhang, Z., Shahinfar, S., Cooper, M. E., Avorn, J., & Brenner, B. M. (2006) · Diabetes Care · doi:10.2337/dc06-0570 · Cited by 57
Self-citationHigh glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1
Glogowski, E., Tsiani, E., Zhou, X., Fantus, I. G., & Whiteside, C. I. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00284.x · Cited by 56
Wong, M. G., Perkovic, V., Woodward, M., et al. (2012) · Kidney International · doi:10.1038/ki.2012.383 · Cited by 55
Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?
Lasaridis, A. N., & Sarafidis, P. A. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00864-1 · Cited by 55
Halting the Progression of Chronic Nephropathy
Campbell, R. C., Ruggenenti, P. L., & Remuzzi, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032522.29672.0a · Cited by 53
Blood Pressure Lowering for the Prevention and Treatment of Diabetic Kidney Disease
Thomas, M. C., & Atkins, R. C. (2006) · Drugs · doi:10.2165/00003495-200666170-00005 · Cited by 53
Self-citationDifferential inhibition of mesangial MAP kinase cascade by cyclic nucleotides
Haneda, M., Araki, S., Sugimoto, T., Togawa, M., Koya, D., & Kikkawa, R. (1996) · Kidney International · doi:10.1038/ki.1996.327 · Cited by 53
The Endothelium in Diabetic Nephropathy
Advani, A., & Gilbert, R. E. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.02.006 · Cited by 53
Palmer, A. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg232 · Cited by 53
Parving, H., & Hovind, P. H. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0069-3 · Cited by 52
Rodby, R. A., Chiou, C.-F., Borenstein, J. E., Smitten, A. L., Sengupta, N., Palmer, A. J., Roze, S., Annemans, L., Simon, T. A., Chen, R. S., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80208-4 · Cited by 51
Forsblom, C. M., Moran, J. L., Harjutsalo, V., Loughman, T., Wadén, J., Tolonen, N., Thorn, L. M., Saraheimo, M., Gordin, D., Groop, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0225 · Cited by 51
Self-citationCampbell, K. H., Huang, E. S., Dale, W., Parker, M. M., John, P. M., Young, B. A., Moffet, H. H., Laiteerapong, N., & Karter, A. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.039 · Cited by 50
Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
Kim, A. J., Lim, H. J., Ro, H., Ko, K., Han, S. Y., Chang, J. H., Lee, H. H., Chung, W., & Jung, J. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104179 · Cited by 49
A basis for accelerated progression of diabetic nephropathy in Pima Indians
Lemley, K. V. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.9.x · Cited by 48
Lee, C. C., Sharp, S. J., Wexler, D. J., & Adler, A. (2010) · Diabetes Care · doi:10.2337/dc09-2245 · Cited by 48
Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes
Harvey, J. N. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200305000-00015 · Cited by 46
Obesity-related glomerulopathy and the nephron complement
Tsuboi, N., Utsunomiya, Y., & Hosoya, T. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft258 · Cited by 46
Ren, S., Xin, C., Beck, K., Saleem, M. A., Mathieson, P. W., Pavenstädt, H., Pfeilschifter, J. M., & Huwiler, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.158 · Cited by 45
Zhao, X., & Li, L. (2008) · American Journal of Nephrology · doi:10.1159/000116885 · Cited by 45
Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications
Thomas, M. C. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.004 · Cited by 45
Self-citationSmoking in diabetic nephropathy: sparks in the fuel tank?
Chakkarwar, V. A. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i12.186 · Cited by 45
Kuriyama, S., Tomonari, H., Tokudome, G., Horiguchi, M., Hayashi, H., Kobayashi, H., Ishikawa, M., & Hosoya, T. (2002) · Hypertension Research · doi:10.1291/hypres.25.849 · Cited by 44
Ruilope, L. M., Agarwal, R., Chan, J. C. N., Cooper, M. E., Gansevoort, R. T., Haller, H. G., Remuzzi, G., Rossing, P. R., Schmieder, R. E., Nowack, C., et al. (2014) · American Journal of Nephrology · doi:10.1159/000371497 · Cited by 43
Self-citationNew Insights Into the Use of Biomarkers of Diabetic Nephropathy
Jha, J. C., Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.008 · Cited by 43
Self-citationHuffel, L. V., Tomson, C., Ruige, J. B., Nistor, I., Biesen, W. V., & Bolignano, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113667 · Cited by 42
Joslin, E. P. (1930) · Annals of Internal Medicine · doi:10.7326/0003-4819-4-1-54 · Cited by 41
Ishizaka, N., Ishizaka, Y., Toda, E.-I., Koike, K., Seki, G., Nagai, R., & Yamakado, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.1035 · Cited by 39
Biswas, S. K., Peixoto, E. B. M. I., Souza, D. S., & de Faria, J. B. L. (2007) · American Journal of Nephrology · doi:10.1159/000109993 · Cited by 39
Murussi, M., Gross, J. L., & Silveiro, S. P. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.07.002 · Cited by 38
Fox, C. S., & Muntner, P. (2008) · Diabetes Care · doi:10.2337/dc07-2348 · Cited by 37
Brenner, B. M., & Zagrobelny, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.16.x · Cited by 34
Preventing microalbuminuria in patients with type 2 diabetes
Jermendy, G., & Ruggenenti, P. L. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.693 · Cited by 32
New therapies for advanced glycation end product nephrotoxicity: Current challenges
Williams, M. E. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50083 · Cited by 30
Where are we in diabetic nephropathy: microRNAs and biomarkers?
McClelland, A., Hagiwara, S., & Kantharidis, P. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000437612.50040.ae · Cited by 30
Treating Hypertension in Diabetic Nephropathy
Tomlinson, J., Owen, K. R., & Close, C. F. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1802 · Cited by 30
Low-Protein Diet for Diabetic Nephropathy
Otoda, T., Kanasaki, K., & Koya, D. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0523-z · Cited by 29
The management of diabetes in indigenous Australians from primary care
Thomas, M., Weekes, A., & Thomas, M. C. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-303 · Cited by 29
Self-citationPhenotypic characteristics of diabetic kidney involvement
Blantz, R. C. (2014) · Kidney International · doi:10.1038/ki.2013.552 · Cited by 29
Prevention and management of chronic kidney disease in type 2 diabetes
Chadban, S. J., Howell, M., Twigg, S. M., Thomas, M. C., Jerums, G., Cass, A., Campbell, D. A., Nicholls, K., Tong, A., Mangos, G., et al. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01240.x · Cited by 29
Self-citationTime course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy
Andersen, S., Jacobsen, P. K., Tarnow, L., Rossing, P. R., Juhl, T. R., & Parving, H.-H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.293 · Cited by 29
Self-citationThe J-Curve in Arterial Hypertension: Fact or Fallacy?
Tsika, E., Poulimenos, L. E., Boudoulas, K. D., & Manolis, A. J. (2014) · Cardiology · doi:10.1159/000362381 · Cited by 29
Krimholtz, M., Karalliedde, J. J., Thomas, S., Bilous, R., & Viberti, G. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110973 · Cited by 28
Watson, A. M. D., Li, J., Samijono, D., Bierhaus, A., Thomas, M. C., Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.945 · Cited by 28
Self-citationNatural history and prognostic factors of diabetic nephropathy in type 2 diabetes
Jude, E. B. (2002) · QJM · doi:10.1093/qjmed/95.6.371 · Cited by 28
Angiotensin‐Converting Enzyme Inhibitors and Type 2 Diabetic Nephropathy: A Meta‐Analysis
Hamilton, R. A., Kane, M. P., & Demers, J. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.909.32726 · Cited by 28
Thomas, W. J., Shen, Y., Molitch, M. E., & Steffes, M. W. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122333 · Cited by 28
Proteinuria: An underappreciated risk factor in cardiovascular disease
Segura, J., Campo, C., & Ruilope, L. M. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0106-5 · Cited by 27
Twelve shifting paradigms in diabetic renal disease and hypertension
Mogensen, C. E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.029 · Cited by 27
Effect of high dose ramipril with or without indomethacin on glomerular selectivity
Pisoni, R., Ruggenenti, P. L., Sangalli, F., Lepre, M. S., Remuzzi, A., & Remuzzi, G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00535.x · Cited by 26
The Pathogenesis and Management of Hypertension in Diabetic Kidney Disease
Buren, P. N. V., & Toto, R. D. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.003 · Cited by 25
Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes
Królewski, A. S., Gohda, T., & Niewczas, M. A. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0900-y · Cited by 24
Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy
Haas, M., Leko-Mohr, Z., Erler, C., & Mayer, G. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34883 · Cited by 24
Parfrey, P. S. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283428bc2 · Cited by 23
Outcome studies in diabetic nephropathy
Mohanram, A., & Toto, R. D. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00061-5 · Cited by 23
Nephropathy in Type 1 Diabetes Is Diminished in Carriers of HLA-DRB1*04
Cordovado, S. K., Zhao, Y., Warram, J. H., Gong, H., Anderson, K. L., Hendrix, M. M., Hancock, L. N., Cleary, P. A., & Mueller, P. W. (2007) · Diabetes · doi:10.2337/db07-0826 · Cited by 22
Treatment of isolated systolic hypertension in diabetes mellitus type 2
Os, I., Gudmundsdottir, H., Kjeldsen, S. E., & Oparil, S. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00523.x · Cited by 21
Derby, L. E., Warram, J. H., Laffel, L. M., & Krolewski, A. S. (1989) · PubMed · Cited by 20
Gnudi, L., & Goldsmith, D. J. A. (2010) · F1000 Medicine Reports · doi:10.3410/m2-18 · Cited by 19
Health‐related quality of life in kidney transplant patients with diabetes
Dukes, J. L., Seelam, S., Lentine, K. L., Schnitzler, M. A., & Neri, L. (2013) · Clinical Transplantation · doi:10.1111/ctr.12198 · Cited by 19
Locatelli, F., Vecchio, L. D., DʼAmico, M., & Andrulli, S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032521.12410.29 · Cited by 19
Rosner, M. H., & Okusa, M. D. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1025 · Cited by 19
Katayama, S., Yagi, S., Yamamoto, H., Yamaguchi, M., Izumida, T., NOGUCHI, Y., Inaba, M., & Inukai, K. (2007) · Hypertension Research · doi:10.1291/hypres.30.529 · Cited by 19
What Is the Ideal Blood Pressure Goal for Patients with Diabetes Mellitus and Nephropathy?
Lipman, M. L., & Schiffrin, E. L. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0308-4 · Cited by 18
Jarrett, R. J. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80107-6 · Cited by 18
How well are hypertension and albuminuria treated in type II diabetic patients?
Boero, R., Prodi, E., Elia, F., Porta, L., Martelli, S., Ferraro, L., & Quarello, F. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001568 · Cited by 17
Relationship Between Low-Normal Blood Pressure and Kidney Disease in Type 1 Diabetes
Shankar, A., Klein, R., Klein, R., Nieto, F. J., & Moss, S. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000252431.75154.3a · Cited by 16
Diabetes and hypertension: How low should you go and with which drugs?
Weir, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01313-9 · Cited by 15
Combination ACE Inhibitors and Angiotensin II Receptor Blockers for Hypertension
Finnegan, P. M., & Gleason, B. L. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c393 · Cited by 15
The impact of disadvantage on the development and progression of diabetic kidney disease
Weil, E. J., Curtis, J. M., Hanson, R. L., Knowler, W. C., & Nelson, R. G. (2011) · Clinical Nephrology · doi:10.5414/cnp74s032 · Cited by 14
Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease
Andersen, N. H., & Mogensen, C. E. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0056-y · Cited by 14
The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study
Atta, M. G., Baptiste-Roberts, K., Brancati, F. L., & Gary‐Webb, T. L. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.07.023 · Cited by 13
Direct renin inhibition in chronic kidney disease
Persson, F., Rossing, P. R., & PARVING, H.-H. D. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12072 · Cited by 13
Self-citationThe assessment and management of albuminuria in primary care
Thomas, M. C. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.024 · Cited by 10
Self-citationEmerging drugs for managing kidney disease in patients with diabetes
Thomas, M. C. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.762356 · Cited by 10
Self-citationAmazonas, R. B., Sanita, R. D. A., Kawachi, H., et al. (2007) · Nephron Physiology · doi:10.1159/000108642 · Cited by 9
An update on proteinuric chronic kidney disease: The dual-goal approach
HIRSCH, S. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.10.705 · Cited by 9
Thomas, B. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.10.005 · Cited by 8
Pham, J. T. (2012) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.s2-003 · Cited by 8
Treatment of Hypertension in Patients with Renal Disease
Garg, J. P., & Bakris, G. L. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1022973928505 · Cited by 6
Assessing renal risk in patients with type 2 diabetes
Thomas, M. C., & Groop, P. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.181 · Cited by 6
Self-citationGæde, P. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.504 · Cited by 6
Crook, E. D., Wofford, P., & Oliver, B. L. (2003) · PubMed · Cited by 5
Newton, C. A., & Raskin, P. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0124-0 · Cited by 5
The evolution of treatment guidelines for diabetic nephropathy
Bakris, G. L. (2003) · Postgraduate Medicine · doi:10.3810/pgm.2003.05.1411 · Cited by 4
Angiotensin blockade in type 2 diabetic renal disease
Ruilope, L. M., & Luño, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.12.x · Cited by 3
Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic
Pavkov, M. L., Knowler, W. C., Bennett, P., et al. (2006) · Cited by 2
Coca, S. G., Ismail-Beigi, F., Haq, N., Krumholz, H. M., & Parikh, C. R. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2230 · Cited by 1
Cited by
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Thomas, M. C., Cooper, M. E., & Zimmet, P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.173 · Cited by 742
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Metadata
- Authors
- Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-07-30
- Volume
- 1
- Issue
- 1
- Pages
- 15018-15018
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2394782024
- Cited by
- 1,230
- References
- 505
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.